THE COMPARATIVE EFFECT OF TREATMENT WITH LISINOPRIL/GLIBENCLAMIDE OR AQUEOUS FRACTION OF CLEOME RUTIDOSPERMA/HUNTERIA UMBELLATA SEED ON BODY WEIGHT, BLOOD GLUCOSE CONCENTRATION, LIPID PROFILE, AND HEMODYNAMICS OF HYPERTENSIVE/DIABETIC WISTAR RATS
Faculty
Department
Year of Publication
Keyword
Publication Type
Abstract
This study evaluated the comparative effects of standard pharmacotherapy (Lisinopril/Glibenclamide) and an aqueous extract combination of Cleome rutidosperma and Hunteria umbellata on metabolic and cardiovascular parameters in hypertensive/diabetic rats. The hypertensive/diabetic rats showed reduced body weight, elevated fasting blood glucose, and increased blood pressure indices confirming disease induction. Treatment with Lisinopril/Glibenclamide significantly restored body weight and normalized blood glucose and blood pressure. The plant extract also improved these parameters, with a more pronounced effect on weight gain, moderate glucose lowering, and significant reductions in systolic, diastolic, and mean arterial pressures. Cardiovascular autonomic function was improved as indicated by heart rate stabilization. Lipid profile analysis revealed that, while standard therapy unexpectedly increased total cholesterol and LDL cholesterol, the combined Cleome/Hunteria extract markedly improved lipid profiles by reducing total cholesterol, LDL cholesterol, triglycerides, and eliminating detectable VLDL levels, while significantly increasing HDL cholesterol. These results suggest that the plant extract may modulate lipid metabolism more effectively than standard drugs. Overall, the findings demonstrate that Cleome rutidosperma and Hunteria umbellata aqueous extract exert beneficial effects on anthropometric, glycemic, hemodynamic, and lipid parameters in hypertensive/diabetic rats. This suggests potential cardiometabolic protective properties via biochemical pathways involving glucose homeostasis, vascular tone regulation, and lipid metabolism. Further mechanistic and clinical investigations are warranted to confirm its therapeutic viability. This summary aligns with literature reporting reduced body weight gain in hypertensive and diabetic rat models due to metabolic derangement and catabolism. The plant extract’s enhancement of body weight may reflect improved anabolic state and nutrient utilization, while its lipid-lowering effect suggests modulation of lipoprotein metabolism enzymes.
Supervisor(s)
co-supervisor


